뒤로
HBM Holdings Limited(2142.HK) 가격
2142.HK 주가 차트
HBM HOLDINGS-B (2142.HK)
HBM Holdings Limited
HK$14.38
-1.03%
$-0.14
장 종료: Jan 16, 16:00:00 HKT
주요 통계
이전 종가
$14.53
시가
$14.53
일일 범위
$14.08 - $14.68
52주 범위
$2.9 - $17.98
거래량
2.8M
평균 거래량
4.4M
EPS(TTM)
0.73
배당수익률
--
시가총액
$12.0B
HBM HOLDINGS-B란 무엇인가요?
HBM Holdings Ltd. is an investment company, which engages in the discovery and development of differentiated antibody therapeutics in oncology and immunology disease areas. The company is headquartered in Suzhou, Jiangsu and currently employs 210 full-time employees. The company went IPO on 2020-12-10. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The firm provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.